PALVELLA THERAPEUTICS, INC. Income Tax Expense (Benefit) in USD from Q3 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Palvella Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2013 to Q3 2025.
  • Palvella Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $0.000.
  • Palvella Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $0.000.
  • Palvella Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2024 was $0.000.
  • Palvella Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Palvella Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

PALVELLA THERAPEUTICS, INC. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 $0 Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $0 $0 $0 Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $0 $0 $0 Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $0 $0 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q4 2019 $0 $0 +$164K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$164K $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 -$164K $0 +$148K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-09
Q1 2019 -$312K $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$312K -$164K -$307K -215% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$5K $0 -$146K -100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $141K -$148K -$962K -118% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $1.1M $0 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $1.1M $143K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $146K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $814K +$814K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $0 $0 Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q2 2016 $204K $0 $0 Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $204K $0 $0 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $204K $163K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $40.4K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $0 +$18.00 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 -$18 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-12

PALVELLA THERAPEUTICS, INC. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $0 $0 Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $0 -$164K -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $164K +$164K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $0 +$312K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$312K -$1.42M -128% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $1.1M +$941K +581% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $162K -$41.9K -20.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $204K +$204K Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$18 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.